7-Day Free Trial
Track ALL executive moves FREE for 7 days - in real-time
Start your free trial with the ONLY platform offering real-time Chrome & Slack alerts. No credit card needed.
✓ 7 days unlimited access • ✓ Proprietary scoring algorithm • ✓ Direct contact info
Your 7-day trial includes:
✓ FULL Starter features
✓ Real-time data & alerts
✓ 10 AI-matched leads daily
No credit card • Full access • Cancel anytime
Dbv Technologies Announces Appointment of Virginie Boucinha As Chief Financial Officer
10/16/23, 6:10 AM
Location
châtillonIndustry
biopharma
biotechnology
Position
chief financial officer
DBV Technologies , a clinical-stage biopharmaceutical company, today announced the appointment of Virginie Boucinha as its Chief Financial Officer, effective November 6, 2023. An experienced financial and operations executive, Virginie will report directly to Daniel Tassé, Chief Executive Officer, and serve as a member of the Executive Committee.
Sébastien Robitaille, Chief Financial Officer, DBV Technologies, will be leaving the Company to pursue other opportunities on November 17 th . Virginie will onboard on November 6, 2023, allowing for a smooth two-week transition between executives.
Company Info
Location
châtillon, ile de france, france
Additional Info
DBV Technologies is a global clinical stage biopharmaceutical company founded by pediatricians who believed that food allergies could one day be treated safely and effectively.
We are on a mission to advance epicutaneous immunotherapy using our innovative technology platform, Viaskin™, to develop treatment options for immunologic diseases with significant unmet medical need.
Related people
H
VH
RH